Case Report

Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma

Table 1

Previous similar cases.

CaseAgeSexDiagnosisTherapyOutcome

Ohtsubo et al. [33]77MaleRecently diagnosed blastoid variant of MCL, lactic acidosisTHP-COP, EPOCH, rituximabSurvived
Diab et al. [34]81MaleRecently diagnosed MCL, lactic acidosis, hypoglycemiaRituximab, cyclophosphamide, vincristine, prednisoneSurvived
Wahab et al. [35]67MaleRecently diagnosed blastoid variant of MCL, lactic acidosis, hyperuricemiaRasburicase, oral allopurinol, dexamethasone, VR-CAPSurvived
Dejman and Riveros [36]66MaleStage IV MCL, lactic acidosis, bladder cancerBendamustine, rituximab, continuous venovenous hemofiltration, IV thiamine, chemotherapyExpired
Chan et al. [14]59MaleRecently diagnosed MCL, lactic acidosisR-CHOP§Survived

Tetrahydropyranyl doxorubicin, cyclophosphamide, vincristine, and prednisolone. Etoposide, prednisone, vincristine, and doxorubicin. Bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone. §Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone. All patients received sodium bicarbonate as part of their therapies.